{"id":"https://openalex.org/W1456701676","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","title":"6\u2032\u2010Guanidinonaltrindole (6\u2032\u2010GNTI) is a potent and functionally unique kappa opioid agonist that displays bias against beta\u2010arrestin recruitment and receptor internalization","display_name":"6\u2032\u2010Guanidinonaltrindole (6\u2032\u2010GNTI) is a potent and functionally unique kappa opioid agonist that displays bias against beta\u2010arrestin recruitment and receptor internalization","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W1456701676","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","mag":"1456701676"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.25.1_supplement.626.2","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/conference_contribution/6_-Guanidinonaltrindole_6_-GNTI_is_a_potent_and_functionally_unique_kappa_opioid_agonist_that_displays_bias_against_beta-arrestin_recruitment_and_receptor_internalization/20829985","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041595412","display_name":"John M. Streicher","orcid":"https://orcid.org/0000-0002-4173-7362","observed_orcids":["https://orcid.org/0000-0002-4173-7362"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Michael Streicher","raw_affiliation_strings":["Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008038011","display_name":"Chad E. Groer","orcid":"https://orcid.org/0000-0002-8589-9304","observed_orcids":["https://orcid.org/0000-0002-8589-9304"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad E Groer","raw_affiliation_strings":["Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040325195","display_name":"Thomas A. Munro","orcid":"https://orcid.org/0000-0002-3366-7149","observed_orcids":["https://orcid.org/0000-0002-3366-7149"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Munro","raw_affiliation_strings":["Mailman Research Center, McLean Hospital, Belmont, MA","Psychiatry, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman Research Center, McLean Hospital, Belmont, MA","institution_ids":["https://openalex.org/I2801148111"]},{"raw_affiliation_string":"Psychiatry, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085625764","display_name":"C\u00e9cile B\u00e9guin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecile Beguin","raw_affiliation_strings":["Mailman Research Center, McLean Hospital, Belmont, MA","Psychiatry, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman Research Center, McLean Hospital, Belmont, MA","institution_ids":["https://openalex.org/I2801148111"]},{"raw_affiliation_string":"Psychiatry, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110194384","display_name":"Bruce M. Cohen","orcid":"https://orcid.org/0000-0002-8861-6285","observed_orcids":["https://orcid.org/0000-0002-8861-6285"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce M Cohen","raw_affiliation_strings":["Mailman Research Center, McLean Hospital, Belmont, MA","Psychiatry, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman Research Center, McLean Hospital, Belmont, MA","institution_ids":["https://openalex.org/I2801148111"]},{"raw_affiliation_string":"Psychiatry, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003815380","display_name":"Laura Bohn","orcid":"https://orcid.org/0000-0002-6474-8179","observed_orcids":["https://orcid.org/0000-0002-6474-8179"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura M Bohn","raw_affiliation_strings":["Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Therapeutics, The Scripps Research Institute - FL, Jupiter, FL","institution_ids":["https://openalex.org/I123431417"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05413278,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6312999725341797,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.35690000653266907,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9490000009536743},{"id":"https://openalex.org/keywords/functional-selectivity","display_name":"functional selectivity","score":0.9559999704360962},{"id":"https://openalex.org/keywords/beta-arrestin-2","display_name":"\u03b2-arrestin2","score":0.777999997138977},{"id":"https://openalex.org/keywords/receptor-internalization","display_name":"receptor internalization","score":0.9810000061988831},{"id":"https://openalex.org/keywords/g-protein-coupling","display_name":"G protein coupling","score":0.9340000152587891},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9810000061988831},{"id":"https://openalex.org/keywords/u69593","display_name":"U69593","score":0.8849999904632568},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.6129999756813049},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C43587935","wikidata":"https://www.wikidata.org/wiki/Q1258877","display_name":"Functional selectivity","level":4,"score":0.8111322522163391},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.740698516368866},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.715459942817688},{"id":"https://openalex.org/C2777503648","wikidata":"https://www.wikidata.org/wiki/Q905671","display_name":"Arrestin","level":4,"score":0.6363487243652344},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.6172258257865906},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5273398160934448},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.478402704000473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46933263540267944},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4143502712249756},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4134103059768677},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4106450378894806},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3952215015888214},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.38405272364616394},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.37916868925094604},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2349793016910553},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1262342929840088}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1096/fasebj.25.1_supplement.626.2","doi":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.25.1_supplement.626.2","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},{"id":"pmh:oai:figshare.com:article/20829985","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/conference_contribution/6_-Guanidinonaltrindole_6_-GNTI_is_a_potent_and_functionally_unique_kappa_opioid_agonist_that_displays_bias_against_beta-arrestin_recruitment_and_receptor_internalization/20829985","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Conference contribution"},{"id":"pmh:oai:figshare.com:article/888606","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/poster/6_Guanidinonaltrindole_6_GNTI_is_a_potent_and_functionally_unique_kappa_opioid_agonist_that_displays_bias_against_beta_arrestin_recruitment_and_receptor_internalization/888606","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Poster"},{"id":"doi:10.6084/m9.figshare.888606.v1","doi":"https://doi.org/10.6084/m9.figshare.888606.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.888606.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/20829985","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/conference_contribution/6_-Guanidinonaltrindole_6_-GNTI_is_a_potent_and_functionally_unique_kappa_opioid_agonist_that_displays_bias_against_beta-arrestin_recruitment_and_receptor_internalization/20829985","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Conference contribution"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6000000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2059628641","https://openalex.org/W2023948580","https://openalex.org/W3173218560","https://openalex.org/W1999561809","https://openalex.org/W2323301233","https://openalex.org/W4389008384","https://openalex.org/W2053539197","https://openalex.org/W2734986932","https://openalex.org/W2952626514","https://openalex.org/W3096797280"],"abstract_inverted_index":{"Functional":[0,16],"selectivity":[1,17],"is":[2,41,49,70,126],"a":[3,20,42,71,96,106,136,161,183],"phenomenon":[4],"whereby":[5],"different":[6],"ligands":[7,191],"activate":[8],"distinct":[9],"signaling":[10,29,168],"cascades":[11],"through":[12],"the":[13,27,65,77,110,123,159,171],"same":[14],"receptor.":[15],"may":[18,180],"offer":[19],"means":[21],"to":[22,122,128],"target":[23],"desired":[24],"aspects":[25],"of":[26,156,195],"receptor":[28,39,47],"response":[30],"while":[31],"avoiding":[32],"unwanted":[33],"side":[34],"effects.":[35],"The":[36],"kappa":[37],"opioid":[38],"(KOR)":[40],"widely":[43],"expressed":[44],"G-protein":[45,81],"coupled":[46],"that":[48,64],"involved":[50],"in":[51,91,150,174,177,202],"modulating":[52],"reward,":[53],"mood,":[54],"sexual":[55],"behavior":[56],"and":[57,83,86,125,176,179],"other":[58],"brain":[59],"functions.":[60],"We":[61],"report":[62],"here":[63],"KOR":[66,92,112,130,172,190,196],"agonist":[67,75,104,113],"6\u2032-guanidinonaltrindole":[68],"(6\u2032-GNTI)":[69],"functionally":[72,166,188],"selective,":[73],"potent":[74],"at":[76,170],"KOR.":[78],"6\u2032-GNTI":[79,117,133,157],"activates":[80],"coupling":[82],"ERK":[84],"MAPK":[85],"alters":[87],"whole":[88],"cell":[89],"impedance":[90],"expressing":[93],"cells":[94],"as":[95,135,200],"partial":[97,137],"(G-protein":[98,138],"coupling)":[99],"or":[100,141],"full":[101,142],"(ERK,":[102],"impedance)":[103],"with":[105],"greater":[107],"potency":[108],"than":[109],"standard":[111],"U69,593.":[114],"In":[115],"contrast,":[116],"weakly":[118],"induces":[119],"beta-arrestin2":[120],"recruitment":[121],"KOR,":[124],"unable":[127],"induce":[129],"internalization.":[131],"Furthermore,":[132],"acts":[134],"coupling,":[139],"ERK)":[140],"(beta-arrestin":[143],"recruitment,":[144],"internalization)":[145],"antagonist":[146],"against":[147],"U69,593":[148],"activity":[149],"these":[151],"assays.":[152],"These":[153],"unique":[154],"features":[155],"make":[158],"drug":[160,203],"useful":[162,184],"tool":[163],"for":[164,186,192],"dissecting":[165],"selective":[167,189],"pathways":[169],"both":[173],"vitro":[175],"vivo,":[178],"also":[181],"provide":[182],"scaffold":[185],"developing":[187],"clinical":[193],"treatment":[194],"related":[197],"disorders,":[198],"such":[199],"dysphoria":[201],"addiction.":[204]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}
